MAUNA KEA TECHNOLOGIES Financials Mauna Kea Technologies
Equities
ALMKT
FR0010609263
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.39 EUR | +2.77% |
|
0.00% | -17.20% |
| Apr. 25 | Mauna Kea Technologies SA Provides Sales Guidance for the Year 2024 | CI |
| Apr. 03 | Mauna Kea: first Italian center for Cellvizio | CF |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 50.56 | 41.68 | 40.19 | 33.85 | 18.48 | 24 | 24 | - |
| Enterprise Value (EV) 1 | 49 | 49.05 | 58.49 | 50.65 | 44.53 | 39.6 | 46.8 | 54.3 |
| P/E ratio | -3.94 x | -2.73 x | -3.13 x | -2.19 x | -1.66 x | 1.63 x | -2.44 x | -2.29 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 7.48 x | 5.61 x | 6.16 x | 4.4 x | 2.47 x | 3.87 x | 3.38 x | 2.93 x |
| EV / Revenue | 7.25 x | 6.6 x | 8.96 x | 6.58 x | 5.95 x | 6.39 x | 6.59 x | 6.62 x |
| EV / EBITDA | -4.71 x | -4.14 x | -5.49 x | -5.54 x | -5.57 x | 2.96 x | -10.9 x | -12.1 x |
| EV / FCF | -4.03 x | -4.21 x | -6.45 x | -4.45 x | -4.96 x | -14.7 x | -37.4 x | -14.9 x |
| FCF Yield | -24.8% | -23.8% | -15.5% | -22.5% | -20.2% | -6.82% | -2.67% | -6.72% |
| Price to Book | 6.35 x | 165 x | -3.33 x | -3.3 x | -0.97 x | -1.86 x | -1.05 x | -0.72 x |
| Nbr of stocks (in thousands) | 25,155 | 30,512 | 30,536 | 44,244 | 44,522 | 61,545 | 61,545 | - |
| Reference price 2 | 2.010 | 1.366 | 1.316 | 0.7650 | 0.4150 | 0.3900 | 0.3900 | 0.3900 |
| Announcement Date | 3/20/19 | 4/28/20 | 5/26/21 | 4/21/22 | 4/6/23 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 6.76 | 7.431 | 6.526 | 7.7 | 7.479 | 6.2 | 7.1 | 8.2 |
| EBITDA 1 | -10.4 | -11.85 | -10.64 | -9.141 | -7.988 | 13.4 | -4.3 | -4.5 |
| EBIT 1 | -12 | -13 | -11.96 | -11.33 | -8.983 | -4.2 | -4.8 | -5.2 |
| Operating Margin | -177.49% | -174.94% | -183.25% | -147.1% | -120.11% | -67.74% | -67.61% | -63.41% |
| Earnings before Tax (EBT) | -12.78 | -15.3 | -12.79 | - | - | - | - | - |
| Net income 1 | -12.78 | -15.3 | -12.79 | -13.44 | -11.18 | 10.7 | -7.2 | -7.5 |
| Net margin | -189.13% | -205.89% | -196% | -174.61% | -149.49% | 172.58% | -101.41% | -91.46% |
| EPS 2 | -0.5100 | -0.5000 | -0.4200 | -0.3500 | -0.2500 | 0.2400 | -0.1600 | -0.1700 |
| Free Cash Flow 1 | -12.15 | -11.65 | -9.071 | -11.37 | -8.974 | -2.7 | -1.25 | -3.65 |
| FCF margin | -179.79% | -156.82% | -139% | -147.68% | -119.99% | -43.55% | -17.61% | -44.51% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 3/20/19 | 4/28/20 | 5/26/21 | 4/21/22 | 4/6/23 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2019 S1 | 2019 S2 | 2020 S1 | 2023 Q2 | 2023 S1 |
|---|---|---|---|---|---|
| Net sales 1 | 3.937 | 3.494 | 2.1 | 2.679 | 6.848 |
| EBITDA | -5.922 | -5.928 | - | - | - |
| EBIT | - | -6.59 | - | - | - |
| Operating Margin | - | -188.61% | - | - | - |
| Earnings before Tax (EBT) | - | -7.175 | - | - | - |
| Net income | - | -7.203 | - | - | - |
| Net margin | - | -206.15% | - | - | - |
| EPS | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 7/17/19 | 4/28/20 | 7/20/20 | 7/20/23 | 7/20/23 |
1EUR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | 7.37 | 18.3 | 16.8 | 26.1 | 15.6 | 22.8 | 30.3 |
| Net Cash position 1 | 1.57 | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | -0.6223 x | -1.719 x | -1.838 x | -3.262 x | 1.164 x | -5.302 x | -6.733 x |
| Free Cash Flow 1 | -12.2 | -11.7 | -9.07 | -11.4 | -8.97 | -2.7 | -1.25 | -3.65 |
| ROE (net income / shareholders' equity) | -103% | -6,036% | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share 2 | 0.3200 | 0.0100 | -0.4000 | -0.2300 | -0.4300 | -0.2100 | -0.3700 | -0.5400 |
| Cash Flow per Share 2 | -0.4300 | -0.3400 | -0.2600 | -0.2700 | -0.2000 | -0.0600 | 0.0400 | -0.0600 |
| Capex 1 | 1.25 | 1.38 | 1.08 | 1.1 | 0.14 | 0.3 | 0.85 | 0.25 |
| Capex / Sales | 18.55% | 18.58% | 16.56% | 14.25% | 1.93% | 4.84% | 11.97% | 3.05% |
| Announcement Date | 3/20/19 | 4/28/20 | 5/26/21 | 4/21/22 | 4/6/23 | - | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.39
EUR
Average target price
1.955
EUR
Spread / Average Target
+401.28%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -17.20% | 25.62M | |
| -12.91% | 19.08B | |
| -46.21% | 2.65B | |
| +18.15% | 1.87B | |
| -3.12% | 1.61B | |
| +23.78% | 1.21B | |
| -10.69% | 1.02B | |
| -20.89% | 905M | |
| -18.10% | 682M | |
| -7.14% | 716M |
- Stock Market
- Equities
- ALMKT Stock
- Financials Mauna Kea Technologies
